Please login to the form below

Not currently logged in

severe hypertriglyceridemia

This page shows the latest severe hypertriglyceridemia news and features for those working in and with pharma, biotech and healthcare.

FDA okays Amarin’s Vascepa for cardiovascular risk reduction

FDA okays Amarin’s Vascepa for cardiovascular risk reduction

Amarin’s drug has been approved since 2012 to reduce triglyceride levels in adult patients with severe hypertriglyceridemia, but the new indication makes the drug an option for many millions of

Latest news

  • AZ target Omthera files blood fat drug in US

    FDA submission for Epanova in severe hypertriglyceridemia. Omthera Pharmaceuticals said yesterday it had submitted its drug Epanova for US approval in the treatment of patients with high levels of the blood ... The company, which is the subject of a

  • AstraZeneca offers $443m to buy Omthera AstraZeneca offers $443m to buy Omthera

    In trials, the product has been shown to reduce triglyceride levels and improve other blood lipid profiles and is due to be filed for approval for severe hypertriglyceridemia in the coming

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...